Report cover image

Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Publisher Koncept Analytics
Published Jun 21, 2022
Length 89 Pages
SKU # KOAN17265393

Description

Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

The global peptide therapeutics market is expected to record a value of US$44.43 billion in 2026, progressing at a CAGR of 6.95%, over the period 2022-2026. The factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs. However, the market growth would be challenged by availability of generic or biosimilar peptide therapeutic drugs, high cost of developing drugs and stringent regulatory requirements and production complexity of peptides. The market is anticipated to experience certain trends like expanding volume of peptides driven by generics, rapid adoption of outsourced peptide API and rising investments in research and development of novel drugs.

The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application. Based on type, the market can be bifurcated into innovative and generic. According to synthesis technology, the market can be categorized into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) and Hybrid Technology. Whereas, on the basis of manufacturing type, the market can be divided outsourced and in-house. In terms of application, the global peptide therapeutics market can be split into chemotherapy, gastroenterology, analgesia, diabetes, pediatric & neonatology and other applications.

The fastest growing regional market is North America due to increasing research and development activities for the development of innovative peptide therapeutics and improvements in healthcare infrastructure coupled with growing prescription of peptide therapeutics on account of high presence of a large number of patients with chronic diseases such as diabetes and cancer.

Scope of the report:
  • The report provides a comprehensive analysis of the global peptide therapeutics market segmented on the basis of type, synthesis technology, manufacturing type and application region.
  • The major regional and country markets (North America, Europe, Middle East & Africa, Asia Pacific and Latin America) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The company profiles of leading players (Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co., Amgen Inc., Eli Lilly and Company and PolyPeptide Group AG) are also presented in detail.
Key Target Audience:
  • Peptide Manufacturers, Suppliers & Distributors
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

89 Pages
1. Market Overview
1.1 Introduction
Table 1: Difference between Peptides, Small Molecules & Biologics
1.2 Manufacturing Process of Peptides
Table 2: Manufacturing Process of Peptides
1.3 Classification of Peptides
Table 3: Classification of Peptides
1.4 Functional Classification of Therapeutic Peptides & Proteins
Table 4: Functional Classification of Therapeutic Peptides & Proteins
1.5 Examples of Peptide-based Drugs
Table 5: Examples of Peptide-based Drugs Available in the Market
1.6 Advantages and Disadvantages of Therapeutic Peptides
Table 6: Advantages and Disadvantages of Therapeutic Peptides
1.7 Source or Chemical Nature of Early Peptides
Table 7: Source or Chemical Nature of Early Peptides
2. Impact of COVID-19
2.1 Adoption of Peptides in COVID-19 Related Research
Table 8: Synthetic Peptides in Development of COVID-19 (2020)
2.2 Disruptions in Clinical Trials
Table 9: Global Most Affected Clinical Trials by Therapy Area (2020)
3. Global Market Analysis
3.1 Global Peptide Therapeutics Market by Value
Table 10: Global Peptide Therapeutics Market by Value (2017-2021)
3.2 Global Peptide Therapeutics Market Forecast by Value
Table 11: Global Peptide Therapeutics Market Forecast by Value (2022-2026)
3.3 Global Peptide Therapeutics Market by Type
Table 12: Global Peptide Therapeutics Market by Type (2021)
3.3.1 Global Innovative Peptide Therapeutics Market by Value
Table 13: Global Innovative Peptide Therapeutics Market by Value (2017-2021)
3.3.2 Global Innovative Peptide Therapeutics Market Forecast by Value
Table 14: Global Innovative Peptide Therapeutics Market Forecast by Value (2022-2026)
3.3.3 Global Generic Peptide Therapeutics Market by Value
Table 15: Global Generic Peptide Therapeutics Market by Value (2017-2021)
3.3.4 Global Generic Peptide Therapeutics Market Forecast by Value
Table 16: Global Generic Peptide Therapeutics Market Forecast by Value (2022-2026)
3.4 Global Peptide Therapeutics Market by Synthesis Technology
Table 17: Global Peptide Therapeutics Market by Synthesis Technology (2021)
3.4.1 Global Solid Phase Peptide Synthesis Therapeutics Market by Value
Table 18: Global Solid Phase Peptide Synthesis Therapeutics Market by Value (2017-2021)
3.4.2 Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value
Table 19: Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2022-2026)
3.4.3 Global Liquid Phase Peptide Synthesis Therapeutics Market by Value
Table 20: Global Liquid Phase Peptide Synthesis Therapeutics Market by Value (2017-2021)
3.4.4 Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value
Table 21: Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2022-2026)
3.4.5 Global Hybrid Technology Synthesis Therapeutics Market by Value
Table 22: Global Hybrid Technology Synthesis Therapeutics Market by Value (2017-2021)
3.4.6 Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value
Table 23: Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value (2021-2025)
3.5 Global Peptide Therapeutics Market by Manufacturing Type
Table 24: Global Peptide Therapeutics Market by Manufacturing Type (2021)
3.5.1 Global Outsourced Peptide Therapeutics Market Forecast by Value
Table 25: Global Outsourced Peptide Therapeutics Market Forecast by Value (2021-2026)
3.5.2 Global In-house Peptide Therapeutics Market Forecast by Value
Table 26: Global In-house Peptide Therapeutics Market Forecast by Value (2021-2026)
3.6 Global Peptide Therapeutics Market by Application
Table 27: Global Peptide Therapeutics Market by Application (2021)
3.6.1 Global Metabolic Disorders Peptide Therapeutics Market by Value
Table 28: Global Metabolic Disorders Peptide Therapeutics Market by Value (2017-2021)
3.6.2 Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value
Table 29: Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
3.6.3 Global Oncology Peptide Therapeutics Market by Value
Table 30: Global Oncology Peptide Therapeutics Market by Value (2017-2021)
3.6.4 Global Oncology Peptide Therapeutics Market Forecast by Value
Table 31: Global Oncology Peptide Therapeutics Market Forecast by Value (2022-2026)
3.6.5 Global Gastrointestinal Disorders Peptide Therapeutics Market by Value
Table 32: Global Gastrointestinal Disorders Peptide Therapeutics Market by Value (2017-2021)
3.6.6 Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value
Table 33: Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
3.6.7 Global Cardiovascular Disorders Peptide Therapeutics Market by Value
Table 34: Global Cardiovascular Disorders Peptide Therapeutics Market by Value (2017-2021)
3.6.8 Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value
Table 35: Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
3.6.9 Global Neurological Disorders Peptide Therapeutics Market by Value
Table 36: Global Neurological Disorders Peptide Therapeutics Market by Value (2017-2021)
3.6.10 Global Neurological Disorders Peptide Therapeutics Market Forecast by Value
Table 37: Global Neurological Disorders Peptide Therapeutics Market Forecast by Value (2022-2026)
3.7 Global Peptide Therapeutics Market by Region
Table 38: Global Peptide Therapeutics Market by Region (2021)
4. Regional Market Analysis
4.1 North America
4.1.1 North America Peptide Therapeutics Market by Value
Table 39: North America Peptide Therapeutics Market by Value (2017-2021)
4.1.2 North America Peptide Therapeutics Market Forecast by Value
Table 40: North America Peptide Therapeutics Market Forecast by Value (2022-2026)
4.1.3 The U.S. Peptide Therapeutics Market Forecast by Value
Table 41: The U.S. Peptide Therapeutics Market Forecast by Value (2021-2026)
4.1.4 The U.S. Peptide Therapeutics Market Forecast by Type
Table 42: The U.S. Peptide Therapeutics Market by Type (2021-2026)
4.2 Europe, Middle East & Africa
4.2.1 Europe, Middle East & Africa Peptide Therapeutics Market by Value
Table 43: Europe, Middle East & Africa Peptide Therapeutics Market by Value (2017-2021)
4.2.2 Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value
Table 44: Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value (2022-2026)
4.3 Asia Pacific
4.3.1 Asia Pacific Peptide Therapeutics Market by Value
Table 45: Asia Pacific Peptide Therapeutics Market by Value (2017-2021)
4.3.2 Asia Pacific Peptide Therapeutics Market Forecast by Value
Table 46: Asia Pacific Peptide Therapeutics Market Forecast by Value (2022-2026)
4.4 Latin America
4.4.1 Latin America Peptide Therapeutics Market by Value
Table 47: Latin America Peptide Therapeutics Market by Value (2017-2021)
4.4.2 Latin America Peptide Therapeutics Market Forecast by Value
Table 48: Latin America Peptide Therapeutics Market Forecast by Value (2022-2026)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Surging Prevalence of Cancer
Table 49: Global Cancer Prevalence (2018-2023)
5.1.2 Rising Healthcare Expenditure
Table 50: Global Healthcare Expenditure Per Capita (2017-2021)
5.1.3 Growing Incidence of Metabolic Disorders
Table 51: Global Diabetes Prevalence (2010-2045)
5.1.4 Increasing Geriatric Population
Table 52: Global Population Ages 65 Years and Above (2017-2021)
5.1.5 Accelerating Number of Approved Peptide-based Therapeutic Drugs
Table 53: Number of Approved/Launched Peptide Therapeutic Drugs Worldwide (2020-2025)
5.2 Key Trends and Developments
5.2.1 Expanding Volume of Peptides driven by Generics
Table 54: Global GLP-1 Market Development (2018-2027)
5.2.2 Rapid Adoption of Outsourced Peptide API
Table 55: Global In-House vs. Outsourced Peptide API Market Development (2020-2025)
5.2.3 Rising Investments in Research and Development of Novel Drugs
Table 56: Global Spending on Pharmaceutical Research and Development (2018-2026)
5.3 Challenges
5.3.1 Availability of Generic or Biosimilar Peptide Therapeutic Drugs
Table 57: Global Biosimilar Therapeutic Peptides Market (2020-2025)
5.3.2 High Cost of Developing Drugs and Stringent Regulatory Requirements
5.3.3 Production Complexity of Peptides
6. Company Profiles
6.1 Novartis International AG
6.1.1 Business Overview
6.2 GlaxoSmithKline PLC
6.2.1 Business Overview
6.3 Bristol Myers Squibb Co.
6.3.1 Business Overview
6.4 Amgen Inc.
6.4.1 Business Overview
6.5 Eli Lilly and Company
6.5.1 Business Overview
6.6 PolyPeptide Group AG
6.6.1 Business Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us